|
Feb 24
|
Novo Nordisk A/S (NVO): Among Renaissance Technologies Portfolio’s Top Stock Picks
|
|
Feb 24
|
Semaglutide shortage ends as FDA sets deadline for compounders
|
|
Feb 24
|
Wall Street Thinks This Weight Loss Drug Stock Could More Than 3X Over the Next 12 Months -- and It's Not Eli Lilly or Novo Nordisk
|
|
Feb 23
|
Prediction: These Could Be the Best-Performing Value Stocks Through 2030
|
|
Feb 23
|
Novo Nordisk A/S (NVO): Among the Cheap Pharmaceutical Stocks to Buy According to Analysts
|
|
Feb 22
|
Why Novo Nordisk A/S (NVO) Surged On Friday?
|
|
Feb 21
|
Hims Stock Crashes After FDA Resolves Weight-Loss Drugs Shortage
|
|
Feb 21
|
Sector Update: Health Care Stocks Softer Late Afternoon
|
|
Feb 21
|
Hims & Hers Stock Plummets. The Wegovy Shortage Is Over.
|
|
Feb 21
|
CrowdStrike, Hims & Hers, Rivian: Market Minute
|
|
Feb 21
|
Pfizer Discontinues Hemophilia Gene Therapy Beqvez As Interest Wanes
|
|
Feb 21
|
Analysts explain why Hims & Hers stock is crashing today
|
|
Feb 21
|
Top Midday Stories: UnitedHealth Under DOJ Investigation Over Medicare Billing Practices; Novo Nordisk Resolves Ozempic Shortage
|
|
Feb 21
|
“Novo Nordisk Is Up, But the Market Is Not Rational!” – Jim Cramer on Novo Nordisk A/S (NVO)
|
|
Feb 21
|
Why Novo Nordisk Stock Popped on Friday
|
|
Feb 21
|
Trending tickers: Alibaba, Tesla, Rivian, Novo Nordisk and Standard Chartered
|
|
Feb 21
|
Novo Nordisk A/S (NVO): Is It The Most Oversold Healthcare Stock to Buy Now?
|
|
Feb 21
|
Zealand Pharma AS (ZLDPF) Q4 2024 Earnings Call Highlights: Strong Cash Position and Obesity ...
|
|
Feb 20
|
Is Novo Nordisk A/S (NVO) the Best Global Stock to Buy According to Hedge Funds?
|
|
Feb 19
|
European Equities Close Lower in Wednesday Trading; UK Inflation Rises Higher Than Expected
|